miR-34a inhibits proliferation, migration and invasion of paediatric neuroblastoma cells via targeting HNF4α

References

• Al-Shammari NF, Redha E, Al Hajeri MH. Cervical neonatal neuroblastoma with recurrent SVT. Gulf J Oncol. 2009;6:45–57.
   Google Scholar
• Davidoff AM. Neuroblastoma. Semin Pediatr Surg. 2012;21:2–14.
   PubMed Web of Science ®Google Scholar
• Pinto NR, Applebaum MA, Volchenboum SL, et al. Advances in risk classification and treatment strategies for neuroblastoma. J Clin Oncol. 2015;33:3008–3017.
   PubMed Web of Science ®Google Scholar
• Wang J. Therapeutic advancement of pediatric neuroblastoma. J Pharm. 2018;24:58–61.
   Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16:203–222.
   PubMed Web of Science ®Google Scholar
• Xin C, Buhe B, Hongting L, et al. MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression. FEBS J. 2013;280:855–866.
   PubMed Web of Science ®Google Scholar
• Liu G, Xu Z, Hao D. MicroRNA 451 inhibits neuroblastoma proliferation, invasion and migration by targeting macrophage migration inhibitory factor. Mol Med Rep. 2016;13:2253.
   PubMed Web of Science ®Google Scholar
• Roth SA, Hald ØH, Fuchs S, et al. MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation ofCyclin D1,MCL-1andMYCN. Oncotarget. 2018;9:18160–18179.
   PubMedGoogle Scholar
• Whittle SB, Smith V, Doherty E, et al. Overview and recent advances in the treatment of neuroblastoma. Expert Rev Anticancer Ther. 2017;17:369–386.
   PubMed Web of Science ®Google Scholar
• Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362:2202–2211.
   PubMed Web of Science ®Google Scholar
• Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer. 2015;15:321–333.
   PubMed Web of Science ®Google Scholar
• Kong YW, Ferland-McCollough D, Jackson TJ, et al. microRNAs in cancer management. Lancet Oncol. 2012;13:e249–e258.
   PubMed Web of Science ®Google Scholar
• Sandbothe M, Buurman R, Reich N, et al. The microRNA-449 family inhibits TGF-β-mediated liver cancer cell migration by targeting SOX4. J Hepatol. 2017;66:1012–1021.
   PubMed Web of Science ®Google Scholar
• Ning W, Wei H, Yin D, et al. MicroRNA-195 inhibits proliferation of cervical cancer cells by targeting cyclin D1a. Tumor Biol. 2016;37:4711–4720.
   PubMedGoogle Scholar
• Lau NC, Lim LP, Weinstein EG, et al. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science. 2001;294:858–862.
   PubMed Web of Science ®Google Scholar
• Lan V, Son HV, Trang VL, et al. Methylation profiles of miR34 gene family in Vietnamese patients suffering from breast and lung cancers. Mol Med Rep. 2018;18:2476–2484.
   PubMed Web of Science ®Google Scholar
• Chamani F, Sadeghizadeh M, Masoumi M, et al. Evaluation of MiR-34 family and DNA methyltransferases 1, 3A, 3B gene expression levels in hepatocellular carcinoma following treatment with dendrosomal nanocurcumin. Asian Pac J Cancer Prev. 2016;17:219–224.
   PubMedGoogle Scholar
• Jauhari A, Singh T, Singh P, et al. Regulation of miR-34 family in neuronal development. Mol Neurobiol. 2018;55:936–945.
   PubMed Web of Science ®Google Scholar
• Duan K, Yongchao GE, Zhang X, et al. miR-34a inhibits cell proliferation in prostate cancer by downregulation of SIRT1 expression. Oncol Lett. 2016;5:3223–3227.
   Google Scholar
• Xun C, Chen XG, Hu X, et al. MiR-34a and miR-203 inhibit survivin expression to control cell proliferation and survival in human osteosarcoma cells. J Cancer. 2016;7:1057–1065.
   PubMed Web of Science ®Google Scholar
• Ji LS, Sun XH, Zhou ZH, et al. Research progress of the relationship between hepatocyte nuclear factor 4 alpha and hepatocellular carcinoma. China Med Herald. 2018;15:32–35.
   Google Scholar
• Sugano M, Nagasaka T, Sasaki E, et al. HNF4α as a marker for invasive mucinous adenocarcinoma of the lung. Am J Surg Pathol. 2013;37:211–218.
   PubMed Web of Science ®Google Scholar
• Saandi T, Baraille F, Derbal-Wolfrom L, et al. Regulation of the tumor suppressor homeogene Cdx2 by HNF4α in intestinal cancer. Oncogene. 2013;32:3782–3788.
   PubMed Web of Science ®Google Scholar
• Xiang X. Hepatocyte nuclear factor 4 alpha promotes the invasion, metastasis, and angiogenesis of neuroblastoma cells via targeting matrix metalloproteinase 14. Cancer Lett. 2015;359:187–197.
   PubMed Web of Science ®Google Scholar